[go: up one dir, main page]

Watson et al., 1993 - Google Patents

Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis.

Watson et al., 1993

View PDF
Document ID
6343199937391243498
Author
Watson F
Robinson J
Phelan M
Bucknall R
Edwards S
Publication year
Publication venue
Annals of the rheumatic diseases

External Links

Snippet

OBJECTIVES–The aim of this study was to determine if neutrophils isolated from the blood and synovial fluid of patients with rheumatoid arthritis had patterns of receptor expression resembling those of blood neutrophils from controls which had been activated and primed in …
Continue reading at pmc.ncbi.nlm.nih.gov (PDF) (other versions)

Classifications

    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/5005—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells
    • G01N33/5008—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics
    • G01N33/5044—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving human or animal cells for testing or evaluating the effect of chemical or biological compounds, e.g. drugs, cosmetics involving specific cell types
    • G01N33/5047—Cells of the immune system
    • G01N33/505—Cells of the immune system involving T-cells
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/564—Immunoassay; Biospecific binding assay for pre-existing immune complex or autoimmune disease, i.e. systemic lupus erythematosus, rheumatoid arthritis, multiple sclerosis, rheumatoid factors or complement components C1-C9
    • G—PHYSICS
    • G01—MEASURING; TESTING
    • G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00—Investigating or analysing materials by specific methods not covered by the preceding groups
    • G01N33/48—Investigating or analysing materials by specific methods not covered by the preceding groups biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53—Immunoassay; Biospecific binding assay
    • G01N33/569—Immunoassay; Biospecific binding assay for micro-organisms, e.g. protozoa, bacteria, viruses
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K16/00—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies
    • C07K16/18—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans
    • C07K16/28—Immunoglobulins [IGs], e.g. monoclonal or polyclonal antibodies against material from animals or humans against receptors, cell surface antigens or cell surface determinants
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07K—PEPTIDES
    • C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
    • C07K14/705—Receptors; Cell surface antigens; Cell surface determinants

Similar Documents

Publication Publication Date Title
Watson et al. Receptor expression in synovial fluid neutrophils from patients with rheumatoid arthritis.
Uchiyama et al. A monoclonal antibody (anti-Tac) reactive with activated and functionally mature human T cells. II. Expression of Tac antigen on activated cytotoxic killer T cells, suppressor cells, and on one of two types of helper T cells.
Williams Jr et al. Inhibition of mixed leukocyte culture responses by serum and γ‐globulin fractions from certain patients with connective tissue disorders
Shastri et al. Autoimmune neutropenia [see comments]
US4707443A (en) Soluble interleukin-2 receptor as a disease indicator and a method of assaying the same
Yodoi et al. Lymphocytes bearing Fc receptors for IgE. IV. Formation of IgE-binding factor by rat T lymphocytes.
US5583002A (en) Evaluation and treatment of patients with progressive immunosuppression
EP0634896B1 (en) Evaluation of patients with progressive immunosuppression
Fitchen et al. Monoclonal antibodies to HLA-A, B, and Ia-like antigens inhibit colony formation by human myeloid progenitor cells.
Gupta Immunology of rheumatic diseases
Suciu-Foca et al. A late-differentiation antigen associated with the helper inducer function of human T cells
Thorne et al. Partial purification and biological properties of an eosinophil‐activating factor
Murgita et al. Effects of human alpha-foetoprotein on human B and T lymphocyte proliferation in vitro
Yamada et al. Effect of activation of protein kinase C on CD45 isoform expression and CD45 protein tyrosine phosphatase activity in T cells
Schwab et al. Defective expression of high affinity IL-2 receptors on activated T cells from aged humans
Ferrone et al. Interaction of histocompatibility (HL-A) antibodies and complement with synchronized human lymphoid cells in continuous culture
Samstag et al. Dephosphorylation of pp19: a common second signal for human T cell activation mediated through different accessory molecules
Uede et al. IgE-binding factors from mouse T lymphocytes. II. Strain differences in the nature of IgE-binding factor.
Santoli et al. Phenotypic and functional characterization of T cell clones derived from the cerebrospinal fluid of multiple sclerosis patients.
Hirano et al. In vitro immune response of human peripheral lymphocytes: IV. Specific induction of human suppressor T cells by an antiserum to the T leukemia cell line HSB
Weisbart et al. Cellular immunity to autologous IgG in rheumatoid arthritis and rheumatoid-like disorders
Wilkins et al. Generation of interleukin-2-dependent T cell lines from synovial fluids in rheumatoid arthritis
Hofman et al. T cell chronic lymphocytic leukaemia with suppressor phenotype
Kagan et al. Failure of the human autologous mixed lymphocyte reaction in the absence of foreign antigens
US6335174B1 (en) Oncofetal antigen specific t-lymphocyte mediated immune response: manipulation and uses of oncofetal antigen specific CD4, CD8 cytotoxic and suppressor T cells and interleukin-10